News and Trends 28 Feb 2023
GC Biopharma acquiring hemophilia rare disease pipeline
GC Biopharma Corp., a South Korean provider of biopharmaceutical products, has signed an asset purchase agreement with Catalyst Biosciences to acquire three programs related to the orphan hematology disorders. The…